In fact, NCOA3 is considered to be a new player in melanoma susceptibility, and in a recent editorial, its function as an activator of cyclins and in-activator of p53, p21 and the cell cycle checkpoint regulator CHK2 was emphasized [76]. Here, TP53 is linked to melanoma.